Rachel M. Layman
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Molecular Biology
- Genetics top 5%
- Co-authors
- Ewa MrózekCharles L. ShapiroJanice K. Kiecolt‐GlaserWilliam B. MalarkeyCharles F. EmeryJeanette M. BennettRonald GlaserRebecca Andridge
- Topics
- Advanced Breast Cancer Therapies (48 papers)Breast Cancer Treatment Studies (35 papers)HER2/EGFR in Cancer Research (31 papers)
- Partner nations
- United StatesItalySouth Korea
In The Last Decade
Rachel M. Layman
95 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 124
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 716
- Cancer Research 518
- Molecular Biology 442
- Genetics 194
Countries citing papers authored by Rachel M. Layman
This map shows the geographic impact of Rachel M. Layman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel M. Layman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel M. Layman more than expected).
Fields of papers citing papers by Rachel M. Layman
This network shows the impact of papers produced by Rachel M. Layman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel M. Layman. The network helps show where Rachel M. Layman may publish in the future.
Co-authorship network of co-authors of Rachel M. Layman
This figure shows the co-authorship network connecting the top 25 collaborators of Rachel M. Layman. A scholar is included among the top collaborators of Rachel M. Layman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel M. Layman. Rachel M. Layman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 9 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 2 | |
| 11 | 1 | |
| 12 | 3 | |
| 13 | 16 | |
| 14 | 24 | |
| 15 | 2 | |
| 16 | 7 | |
| 17 | 54 | |
| 18 | 29 | |
| 19 | 209 | |
| 20 | 19 |
About Rachel M. Layman
Rachel M. Layman is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 105 papers that have together received 2.0k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (48 papers), Breast Cancer Treatment Studies (35 papers) and HER2/EGFR in Cancer Research (31 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (518 citations) and Pulmonary and Respiratory Medicine (716 citations). Rachel M. Layman has collaborated with scholars based in United States, Italy and South Korea. Frequent co-authors include Ewa Mrózek, Charles L. Shapiro, Janice K. Kiecolt‐Glaser, William B. Malarkey, Charles F. Emery, Jeanette M. Bennett, Ronald Glaser, Rebecca Andridge, Juan Peng and Adam Brufsky. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.